Vivo Bio Tech Ltd. (BSE: 511509) is a Hyderabad, Telangana-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹28 Cr, it ranks #4,344 by market cap among the 6,189 Indian listed companies on FinBizNet, and #9 of 10 in Life Sciences Tools and Services. At ₹12.70 (as of 26 Oct 2026), the share price is 37.9% below its 52-week high of ₹20.44 and 5.2% above its 52-week low of ₹12.07. The share price is down 55.7% over one year and down 30.0% over three months.
| Current Price | ₹12.70 |
|---|---|
| Market Cap | ₹28 Cr |
| BSE Code | 511509 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | -15.5 |
| Return on Equity | -2.00% |
| Return on Assets | 4.21% |
| 52-Week Range | ₹12.07 – ₹20.44 |
| 1-Year Price Change | -55.7% |
| 3-Month Price Change | -30.0% |
| Beta (1Y) | 0.72 |
| Headquarters | Hyderabad, Telangana |
| Website | www.vivobio.com |
| Revenue | ₹14 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 1.3% |
| EPS (Basic) | ₹0.08 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents’ evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.
1. Bio Technology-This segment provides drug development and discovery services to pharmaceutical and biotech companies. It offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, etc.
1. Bio Technology-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Indegene Ltd | ₹13,777 Cr | 34.4 | 13.94% | ₹1,063 Cr | +5.9% |
| Suven Life Sciences Ltd. | ₹7,397 Cr | -21.6 | -78.80% | ₹4 Cr | +30.6% |
| Vimta Labs Ltd | ₹2,096 Cr | 27.3 | 18.55% | ₹109 Cr | -32.5% |
| Tarsons Products Limited | ₹1,596 Cr | 111.5 | 2.26% | ₹110 Cr | +3.3% |
| Bilcare Ltd. | ₹207 Cr | 115.5 | -5.21% | — | — |
| Brooks Laboratories Ltd. | ₹170 Cr | 6.9 | 22.28% | ₹23 Cr | -53.0% |
| Jeevan Scientific Technology Ltd | ₹163 Cr | 119.6 | 1.68% | — | +34.0% |
| Dr. Habeebbullal Life Sciences Ltd | ₹31 Cr | -3.4 | -68.79% | — | -32.7% |
| Vivo Bio Tech Ltd. | ₹28 Cr | -15.5 | -2.00% | ₹14 Cr | -55.7% |
Listed by market capitalisation. Ratios are shown for context only.
Vivo Bio Tech Ltd. is trading at ₹12.70, with a market capitalisation of ₹28 Cr.
Vivo Bio Tech Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Vivo Bio Tech Ltd. has a P/E of -15.5 and a return on equity of -2.00%.
Vivo Bio Tech Ltd. is listed on the BSE under the scrip code 511509.
Vivo Bio Tech Ltd.'s share price is down 55.7% over one year and down 30.0% over three months. Its 52-week range is ₹12.07 to ₹20.44.
In Q1 FY27, Vivo Bio Tech Ltd. reported revenue of ₹14 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.08 (standalone, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.